Fulcrum Therapeutics, Inc. (FULC) SEC filings
FULC SEC filings moved a median of +0.49% by the close. FULC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the FULC overview →
60 measured FULC SEC filing events.
Where these FULC SEC filings landedvs 57 measured FULC SEC filing reactions
| Middle 50% of FULC SEC filing reactions | -3.47% to +3.69% |
|---|---|
| Median reaction (to close) | +0.49% |
| Measured reactions | 57 |
Point-in-time · zero look-ahead
Half of the 57 FULC SEC filing events with a measured close landed between -3.47% and +3.69%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-4/A Fulcrum Therapeutics, | SEC filing · Form S-4 | +0.27% | +0.53% | |
| Form S-4 Fulcrum Therapeutics, | SEC filing · Form S-4 | +0.26% | -0.77% | |
| Form 8-K Fulcrum Therapeutics, For: Aug 16 | SEC filing · Form 8-K | +1.57% | +0.79% | |
| Form 8-K Fulcrum Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -0.13% | — | |
| Form 10-Q Fulcrum Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.34% | -3.76% | |
| Form 8-K Fulcrum Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +0.55% | +5.26% | |
| Form 8-K Fulcrum Therapeutics, For: Jun 05 | SEC filing · Form 8-K | -0.28% | -3.09% | |
| Form 8-K Fulcrum Therapeutics, For: May 31 | SEC filing · Form 8-K | +1.09% | +10.15% | |
| Form 8-K Fulcrum Therapeutics, For: Jun 01 | SEC filing · Form 8-K | +0.16% | +0.96% | |
| Form ARS Fulcrum Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.70% | +3.52% | |
| Form DEF 14A Fulcrum Therapeutics, For: Jun 24 | SEC filing · Form DEF | +0.70% | +3.52% | |
| Form DEFA14A Fulcrum Therapeutics, | SEC filing · Form DEFA14A | +0.70% | +3.52% | |
| Form 10-Q Fulcrum Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -9.75% | -2.28% | |
| Form 8-K Fulcrum Therapeutics, For: Apr 23 | SEC filing · Form 8-K | -9.75% | -2.28% | |
| Form 10-K Fulcrum Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.59% | -11.09% | |
| Form 8-K Fulcrum Therapeutics, For: Feb 24 | SEC filing · Form 8-K | -2.59% | -11.09% | |
| Form S-8 Fulcrum Therapeutics, | SEC filing · Form S-8 | -2.59% | -11.09% | |
| Form 8-K Fulcrum Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -1.73% | -8.47% | |
| Form 8-K Fulcrum Therapeutics, For: Dec 10 | SEC filing · Form 8-K | -1.11% | -5.54% | |
| Form 8-K Fulcrum Therapeutics, For: Dec 08 | SEC filing · Form 8-K | +7.17% | +0.23% | |
| Form 10-Q Fulcrum Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.36% | -3.70% | |
| Form 8-K Fulcrum Therapeutics, For: Oct 29 | SEC filing · Form 8-K | -0.36% | -3.70% | |
| Form 8-K Fulcrum Therapeutics, For: Aug 28 | SEC filing · Form 8-K | +0.22% | -2.63% | |
| Form 10-Q Fulcrum Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +8.76% | — | |
| Form 8-K Fulcrum Therapeutics, For: Jul 29 | SEC filing · Form 8-K | +8.76% | — | |
| Form 8-K Fulcrum Therapeutics, For: Jun 26 | SEC filing · Form 8-K | -0.84% | -3.10% | |
| Form DEFR14A Fulcrum Therapeutics, | SEC filing · Form DEFR14A | -2.17% | +6.92% | |
| Form 10-Q Fulcrum Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.78% | +13.77% | |
| Form 8-K Fulcrum Therapeutics, For: May 01 | SEC filing · Form 8-K | -0.78% | +13.77% | |
| Form ARS Fulcrum Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.78% | +13.77% | |
| Form DEF 14A Fulcrum Therapeutics, For: Apr 25 | SEC filing · Form DEF | -0.78% | +13.77% | |
| Form DEFA14A Fulcrum Therapeutics, | SEC filing · Form DEFA14A | -0.78% | +13.77% | |
| Form 8-K Fulcrum Therapeutics, For: Feb 26 | SEC filing · Form 8-K | +0.91% | -1.22% | |
| Form 10-K Fulcrum Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.47% | +3.35% | |
| Form 8-K Fulcrum Therapeutics, For: Feb 25 | SEC filing · Form 8-K | -4.47% | +3.35% | |
| Form S-8 Fulcrum Therapeutics, | SEC filing · Form S-8 | -4.47% | +3.35% | |
| Form 8-K Fulcrum Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -3.24% | -3.47% | |
| Form 8-K Fulcrum Therapeutics, For: Dec 18 | SEC filing · Form 8-K | -1.49% | -3.19% | |
| Form 10-Q Fulcrum Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -7.87% | -9.64% | |
| Form 8-K Fulcrum Therapeutics, For: Nov 13 | SEC filing · Form 8-K | -7.87% | -9.64% | |
| Form 8-K Fulcrum Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -7.87% | -9.64% | |
| Form 8-K Fulcrum Therapeutics, For: Sep 24 | SEC filing · Form 8-K | -0.94% | +8.10% | |
| Form 8-K Fulcrum Therapeutics, For: Sep 12 | SEC filing · Form 8-K | -0.42% | -2.83% | |
| Form 8-K Fulcrum Therapeutics, For: Aug 21 | SEC filing · Form 8-K | +0.45% | +3.50% | |
| Form 10-Q Fulcrum Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -6.20% | +3.69% | |
| Form 8-K Fulcrum Therapeutics, For: Jul 31 | SEC filing · Form 8-K | -6.20% | +3.69% | |
| Form S-8 Fulcrum Therapeutics, | SEC filing · Form S-8 | -6.20% | +3.69% | |
| Form 8-K Fulcrum Therapeutics, For: Jun 17 | SEC filing · Form 8-K | -1.37% | -7.29% | |
| Form 10-Q Fulcrum Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.20% | -11.98% | |
| Form 8-K Fulcrum Therapeutics, For: May 11 | SEC filing · Form 8-K | -1.20% | -11.98% | |
| Form EFFECT Fulcrum Therapeutics, | SEC filing · Form EFFECT | +0.00% | +0.00% | |
| Form ARS Fulcrum Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.14% | +4.32% | |
| Form DEF 14A Fulcrum Therapeutics, For: Jun 17 | SEC filing · Form DEF | +0.14% | +4.32% | |
| Form DEFA14A Fulcrum Therapeutics, | SEC filing · Form DEFA14A | +0.14% | +4.32% | |
| Form 10-K Fulcrum Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.49% | +0.49% | |
| Form 8-K Fulcrum Therapeutics, For: Feb 27 | SEC filing · Form 8-K | -0.10% | +1.80% | |
| Form S-3 Fulcrum Therapeutics, | SEC filing · Form S-3 | +0.49% | +0.49% | |
| Form S-8 Fulcrum Therapeutics, | SEC filing · Form S-8 | +0.49% | +0.49% | |
| Form 10-Q Fulcrum Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +12.57% | +14.71% | |
| Form 8-K Fulcrum Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +12.57% | +14.71% |
Keep exploring
More FULC: earnings → · analyst actions → · FULC overview →